StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$17.50−2.37 (-11.93%)

Close on Nov 17, 2026Market cap $96.14MP/E –Yield –

InMed Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

InMed Pharmaceuticals's enterprise value was $6.77M on Nov 3, 2026, against -$5.94M a year earlier. Over the last 5 years it ranged from -$9.78M to $6.77M, with a median of -$4.49M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 3, 2026$6.77M–
2025Dec 31, 2025-$6.64M–
2024Dec 31, 2024-$2.44M–
2023Dec 29, 2023-$5.42M–
2022Dec 30, 2022-$7.56M–
2021Dec 31, 2021-$1.86M-114.7%
2020Dec 31, 2020$12.63M–

More InMed Pharmaceuticals figures

See a number that looks wrong?